Mizuho Medy Co Ltd
TSE:4595
Mizuho Medy Co Ltd
Intangible Assets
Mizuho Medy Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Mizuho Medy Co Ltd
TSE:4595
|
Intangible Assets
¥36m
|
CAGR 3-Years
36%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Terumo Corp
TSE:4543
|
Intangible Assets
¥800.5B
|
CAGR 3-Years
14%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
Olympus Corp
TSE:7733
|
Intangible Assets
¥104.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Sysmex Corp
TSE:6869
|
Intangible Assets
¥93B
|
CAGR 3-Years
11%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
|
JEOL Ltd
TSE:6951
|
Intangible Assets
¥3.8B
|
CAGR 3-Years
17%
|
CAGR 5-Years
12%
|
CAGR 10-Years
18%
|
|
|
Fukuda Denshi Co Ltd
TSE:6960
|
Intangible Assets
¥1.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-4%
|
|
Mizuho Medy Co Ltd
Glance View
Mizuho Medy Co., Ltd. engages in the research, development, manufacture and distribution of in-vitro diagnostic products. The company is headquartered in Tosu-Shi, Saga-Ken and currently employs 173 full-time employees. The company went IPO on 2015-12-17. The firm mainly provides in-vitro diagnostic pharmaceuticals, including immune serum test drugs, biochemical test drugs, urine and feces test drugs, microbial test drugs, blood test drugs, pathological test drugs and others, in hospital and medical practitioner fields. In addition, the Company also provides over-the-counter (OTC) drugs to pharmacies and drug stores, and sells fruit tree virus test drugs to which they apply the technology of immune serology test to agricultural test centers.
See Also
What is Mizuho Medy Co Ltd's Intangible Assets?
Intangible Assets
36m
JPY
Based on the financial report for Dec 31, 2025, Mizuho Medy Co Ltd's Intangible Assets amounts to 36m JPY.
What is Mizuho Medy Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
24%
Over the last year, the Intangible Assets growth was 260%. The average annual Intangible Assets growth rates for Mizuho Medy Co Ltd have been 36% over the past three years , 24% over the past five years .
